Volume : 08, Issue : 08, August – 2021

Title:

55.ASSOCIATION OF SERUM FETUIN-A WITH β -CELL DYSFUNCTION IN FIRST DEGREE RELATIVES OF TYPE 2 DIABETICS

Authors :

Nazia Shahzadi, Rukhshan Khurshid, Maira Mahmood, Huma Ashraf, Imran Abdullah, Rehan Abdullah

Abstract :

Objectives: To determine the relationship between serum Fetuin-A and β cell function in adolescents with family history of type 2 diabetes mellitus ( T2DM)
Background: Increased level of circulating Fetuin-A, may alter both maturity and adaptive ability of β cells in response to glucose and increase the progression of T2DM. Genetic factors may have a role in the formation of immature β cells resulting in altered functioning of β cells.
Methods: The study population included adolescents with family history of T2DM. The study variables included age, sex, fasting blood sugar (BSF), serum insulin and serum Fetuin-A. 70 adolescents first degree relatives (FDR) of diabetics and 50 controls aged 18 to 20 years were included. Insulin resistance and β-cell function were examined by using a homeostatic model assessment. Data was statistically analyzed by student’s ‘t’ test and Pearson Correlation Coefficient.
Results: Significantly increased level of Fetuin-A was related with increased level of BSF, serum insulin and insulin resistance in both male as well as female study subjects. Similarly, it is also associated with decreased β cell function in both genders (indirect correlation).
Conclusion: This study highlights the significance of Fetuin-A as a predictor of β cell functionality in non-diabetics with positive family history.
Keywords: Type 2 Diabetes Mellitus (T2DM) , Fetuin-A, β cells function , Fasting blood sugar(BSF)

Cite This Article:

Please cite this article in press Nazia Shahzadi et al., Association Of Serum Fetuin-A With β -Cell Dysfunction In First Degree Relatives Of Type 2 Diabetics.., Indo Am. J. P. Sci, 2021; 08(08).

Number of Downloads : 10

References:

[1] Shao A, Drewnowski A, Willcox DC, Krämer L, Lausted C, Eggersdorfer M, et al. Optimal nutrition and the ever-changing dietary landscape: a conference report. Eur J Nutr 2017;56:1–21.
[2] Ježek P, Jabůrek M, Plecitá-Hlavatá L. Contribution of oxidative stress and impaired biogenesis of pancreatic β-cells to type 2 diabetes. Antioxid Redox Signal 2019;31:722–51.
[3] Huang C, Walker EM, Dadi PK, Hu R, Xu Y, Zhang W, et al. Synaptotagmin 4 regulates pancreatic β cell maturation by modulating the Ca2+ sensitivity of insulin secretion vesicles. Dev Cell 2018;45:347–61.
[4] Alessandra G, Algerta M, Paola M, Carsten S, Cristina L, Paolo M, et al. Shaping pancreatic β-cell differentiation and functioning: the influence of mechanotransduction. Cells 2020;9:413.
[5] Kushner JA. The role of aging upon β cell turnover. J Clin Invest 2013;123:990–5.
[6] Henquin J, Nenquin M. Immaturity of insulin secretion by pancreatic islets isolated from one human neonate. J Diabetes Investig 2018;9:270–3.
[7] Dhawan S, Tschen S-I, Zeng C, Guo T, Hebrok M, Matveyenko A, et al. DNA methylation directs functional maturation of pancreatic β cells. J Clin Invest 2015;125:2851–60.
[8] Cerf ME. Beta cell dysfunction and insulin resistance. Front Endocrinol (Lausanne) 2013;4:37.
[9] Gerst F, Kemter E, Lorza-Gil E, Kaiser G, Fritz A-K, Nano R, et al. The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells. Diabetologia 2021;64:1358–74.
[10] Gerst F, Wagner R, Kaiser G, Panse M, Heni M, Machann J, et al. Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion. Diabetologia 2017;60:2240–51.
[11] Khadir A, Kavalakatt S, Madhu D, Hammad M, Devarajan S, Tuomilehto J, et al. Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation. Lipids Health Dis 2018;17:1–13.
[12] Liu S, Hu W, He Y, Li L, Liu H, Gao L, et al. Serum Fetuin-A levels are increased and associated with insulin resistance in women with polycystic ovary syndrome. BMC Endocr Disord 2020;20:1–7.
[13] Cree-Green M, Triolo TM, Nadeau KJ. Etiology of insulin resistance in youth with type 2 diabetes. Curr Diab Rep 2013;13:81–8.
[14] Guo VY, Cao B, Cai C, Cheng KK, Cheung BMY. Fetuin-A levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis. Acta Diabetol 2018;55:87–98.
[15] DeFronzo RA, Eldor R, Abdul-Ghani M. Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care 2013;36:S127–38.
[16] Saisho Y. β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes. World J Diabetes 2015;6:109.
[17] Li Y, Feng D, Esangbedo IC, Zhao Y, Han L, Zhu Y, et al. Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study. BMJ Open Diabetes Res Care 2020;8:e000724.
[18] Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 2020;21:6275.
[19] Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev 2018;98:2133–223.
[20] Yin L, Cai W, Chang X, Li J, Su X, Zhu L, et al. Association between fetuin‑A levels with insulin resistance and carotid intima‑media thickness in patients with new‑onset type 2 diabetes mellitus. Biomed Reports 2014;2:839–42.
[21] Roshanzamir F, Miraghajani M, Rouhani MH, Mansourian M, Ghiasvand R, Safavi SM. The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies. J Endocrinol Invest 2018;41:33–47.
[22] Bourebaba L, Marycz K. Pathophysiological implication of Fetuin-A glycoprotein in the development of metabolic disorders: a concise review. J Clin Med 2019;8:2033.
[23] Ward K, Mulder E, Frings-Meuthen P, O’Gorman DJ, Cooper D. Fetuin-A as a potential biomarker of metabolic variability following 60 days of bed rest. Front Physiol 2020;11.
[24] Jensen MK, Bartz TM, Djoussé L, Kizer JR, Zieman SJ, Rimm EB, et al. Genetically elevated fetuin-A levels, fasting glucose levels, and risk of type 2 diabetes: the cardiovascular health study. Diabetes Care 2013;36:3121–7.
[25] Song A, Xu M, Bi Y, Xu Y, Huang Y, Li M, et al. Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults. PLoS One 2011;6:e19228.